Source: European Medicines Agency (EU) Revision Year: 2020 Publisher: Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, Netherlands
Feraccru 30 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Capsules, hard. Red capsule (19 mm long x 7 mm diameter). |
Each capsule contains 30 mg iron (as ferric maltol).
Excipient(s) with known effect: Each capsule contains 91.5 mg of lactose, 0.5 mg of Allura Red AC (E129) and 0.3 mg Sunset Yellow FCF (E110).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ferric maltol |
Iron in a stable ferric state as a complex with a trimaltol ligand. The complex is designed to provide, in a controlled way, utilisable iron for uptake across the intestinal wall and transfer to the iron transport and storage proteins in the body (transferrin and ferritin, respectively). The complex dissociates on uptake from the gastro-intestinal tract and the complex itself does not enter the systemic circulation. |
| List of Excipients |
|---|
|
Capsule contents: Lactose Capsule shell: Gelatin |
HDPE bottles with a child-proof polypropylene push-lock. Each bottle contains 56 capsules.
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, Netherlands
EU/1/15/1075/001
Date of first authorisation: 18 February 2016
| Drug | Countries | |
|---|---|---|
| FERACCRU | Austria, Estonia, Finland, Croatia, Ireland, Lithuania, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
